Bard
This article was originally published in The Gray Sheet
Executive Summary
Consistent 12% growth is expected in the foreseeable future, Bard predicts, after posting 9% growth in revenues during the first quarter. The announcement follows the company's aborted merger with Tyco in February (1"The Gray Sheet" Feb. 4, 2002, p. 13)...
You may also be interested in...
Tyco Stock Slide Leaves Bard Shortchanged On Merger Deal
Tyco now appears to be $1 bil. short in its effort to complete the acquisition of urology devices maker C.R. Bard
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.